147 related articles for article (PubMed ID: 17348432)
1. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome.
Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K
Anticancer Res; 2007; 27(1B):491-7. PubMed ID: 17348432
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the long-term results of brachytherapy for T1-2N0 oral tongue cancer treated with Ir-192 and Ra-226.
Yamazaki H; Inoue T; Koizumi M; Yoshida K; Kagawa K; Shiomi H; Nose T; Tanaka E; Teshima T; Nakamura H; Shimizutani K; Furukawa S; Fuchihata H; Inoue T
Anticancer Res; 1997; 17(4A):2819-22. PubMed ID: 9252722
[TBL] [Abstract][Full Text] [Related]
3. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
[TBL] [Abstract][Full Text] [Related]
4. High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
Umeda M; Komatsubara H; Nishimatsu N; Yokoo S; Shibuya Y; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):667-70. PubMed ID: 11077395
[TBL] [Abstract][Full Text] [Related]
5. Age as a prognostic factor for late local recurrence of early tongue cancer treated with brachytherapy.
Yamazaki H; Inoue T; Koizumi M; Yoshida K; Kagawa K; Shiomi H; Imai A; Tanaka E; Teshima T; Nakamura H; Shimizutani K; Furukawa S; Fuchihata H; Inoue T
Anticancer Res; 1997; 17(6D):4709-12. PubMed ID: 9494593
[TBL] [Abstract][Full Text] [Related]
6. Tongue cancer treated with brachytherapy: is thickness of tongue cancer a prognostic factor for regional control?
Yamazaki H; Inoue T; Teshima T; Tanaka E; Koizumi M; Kagawa K; Imai A; Yoshida K; Shiomi H; Shimizutani K; Furukawa S; Fuchihata H; Nakamura H; Inoue T
Anticancer Res; 1998; 18(2B):1261-5. PubMed ID: 9615798
[TBL] [Abstract][Full Text] [Related]
7. [Brachytherapy--carcinoma of the tongue].
Jingu K; Hayabuchi N; Matsui M; Wada S; Miyoshi M; Uehara S; Shimamura Y; Hirata H; Ariji E; Moriguchi S
Gan No Rinsho; 1987 Oct; 33(13):1609-18. PubMed ID: 3694797
[TBL] [Abstract][Full Text] [Related]
8. Base-of-tongue cancer: survival, function, and quality of life after external-beam irradiation and brachytherapy.
Robertson ML; Gleich LL; Barrett WL; Gluckman JL
Laryngoscope; 2001 Aug; 111(8):1362-5. PubMed ID: 11568569
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early tongue carcinoma with brachytherapy: results over a 25-year period.
Urashima Y; Nakamura K; Shioyama Y; Nomoto S; Ohga S; Toba T; Yoshitake T; Chikui T; Kawazu T; Jingu K; Terashima H; Honda H
Anticancer Res; 2007; 27(5B):3519-23. PubMed ID: 17972511
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Anticancer Res; 2006; 26(5B):3933-7. PubMed ID: 17094424
[TBL] [Abstract][Full Text] [Related]
11. [High-dose-rate brachytherapy with local injection of bleomycin for N0 oral tongue cancer--possibilities of the control of tumor implant by inserting applicators and the decrease in tumor dose].
Ohga S; Uehara S; Miyoshi M; Jingu K
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jan; 63(1):47-50. PubMed ID: 12645123
[TBL] [Abstract][Full Text] [Related]
12. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.
Bourgier C; Coche-Déquéant B; Fournier C; Castelain B; Prévost B; Lefebvre JL; Lartigau E
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):434-40. PubMed ID: 16168836
[TBL] [Abstract][Full Text] [Related]
13. Elective neck irradiation on ipsilateral side in patients with early tongue cancer for high-risk group with late cervical lymph node metastasis.
Ito Y; Fuwa N; Kikuchi Y; Yokoi N; Hamajima N; Morita K
Nagoya J Med Sci; 2006 Jan; 68(1-2):53-62. PubMed ID: 16579176
[TBL] [Abstract][Full Text] [Related]
14. [Results of brachytherapy of tongue cancer].
Nishio M; Sakurai T; Kagami Y; Narimatsu N; Saito A; Hareyam M; Sugimori S; Asano K; Takeuchi T; Doi Y
Gan No Rinsho; 1986 Apr; 32(4):339-44. PubMed ID: 3712772
[TBL] [Abstract][Full Text] [Related]
15. Long-term functional outcome of brachytherapy for carcinoma of the mobile tongue: focus on the atrophic change of irradiated tongue.
Urashima Y; Nakamura K; Shioyama Y; Sasaki T; Ohga S; Toba T; Kunitake N; Chikui T; Kawazu T; Yamada T; Terashima H; Honda H
Jpn J Clin Oncol; 2006 Nov; 36(11):681-7. PubMed ID: 17020894
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
17. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue.
Inoue T; Inoue T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169
[No Abstract] [Full Text] [Related]
18. Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older.
Yamazaki H; Yoshida K; Kotsuma T; Yoshioka Y; Koizumi M; Furukawa S; Kakimoto N; Shimizutani K; Nishimura T
Radiat Oncol; 2010 Dec; 5():116. PubMed ID: 21143904
[TBL] [Abstract][Full Text] [Related]
19. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
Khor TH; Tuan JK; Hee SW; Tham IW
Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal evaluation of patients with cancer in the oral tongue, tonsils, or base of tongue--does interstitial radiation dose affect quality of life?
Petruson K; Mercke C; Lundberg LM; Silander E; Hammerlid E
Brachytherapy; 2005; 4(4):271-7. PubMed ID: 16344257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
